MarketCap
Facebook
X
TelegramHancock Jaffe Laboratories, Inc. Total Assets 2011-2026 | HJLI
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Hancock Jaffe Laboratories, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 10.5 K | 3.43 M | 3.56 M | 2.21 M | 1.78 M | 2.87 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.56 M | 10.5 K | 2.31 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
720 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.82 | 3.32 % | $ 335 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 8.11 | -2.0 % | $ 1.22 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.38 | 1.85 % | $ 164 M |  France |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
304 M | $ 2.34 | 2.18 % | $ 51.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.46 | 0.17 % | $ 28.6 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 0.99 | -2.37 % | $ 16.8 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 18.28 | -0.49 % | $ 429 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 11.17 | 1.34 % | $ 400 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 75.03 | 1.63 % | $ 4.09 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LENSAR
LNSR
|
71.4 M | $ 5.98 | -1.81 % | $ 71.5 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.54 | -0.97 % | $ 62.7 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 37.36 | -2.25 % | $ 316 M | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.64 | 0.41 % | $ 538 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 1.06 | 1.44 % | $ 44.4 M | USA |
 |
Butterfly Network
BFLY
|
297 M | $ 4.58 | 2.35 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 10.27 | -4.47 % | $ 407 M |  Curacao |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 84.23 | -0.68 % | $ 11.4 B | USA |
 |
Profound Medical Corp.
PROF
|
77.5 M | $ 6.89 | 0.81 % | $ 208 M | Canada |
 |
Insulet Corporation
PODD
|
3.19 B | $ 155.9 | 0.67 % | $ 11 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.67 | -1.5 % | $ 1.14 B | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.46 | 2.93 % | $ 6.82 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 42.79 | -2.41 % | $ 1.26 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 88.61 | -0.75 % | $ 3.08 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 86.5 | 0.84 % | $ 50.6 B | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 69.14 | 0.29 % | $ 2.35 B | USA |